Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
about
Ligation of the jugular veins does not result in brain inflammation or demyelination in miceAxonal degeneration as a self-destructive defense mechanism against neurotropic virus infectionT cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrinsNeuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration.Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.The importance of NAD in multiple sclerosisResveratrol exacerbates both autoimmune and viral models of multiple sclerosisInflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculatureNeuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosisRegulation of an autoimmune model for multiple sclerosis in Th2-biased GATA3 transgenic mice.Innovative monoclonal antibody therapies in multiple sclerosis.Failed, interrupted and inconclusive trials on relapsing multiple sclerosis treatment: update 2010-2015.Integrin signaling in cancer cell survival and chemoresistanceAlpha2beta1 integrin is the major collagen-binding integrin expressed on human Th17 cells.Metallothionein I as a direct link between therapeutic hematopoietic stem/progenitor cells and cerebral protection in stroke.Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis
P2860
Q27306416-D15AC786-15D7-47D9-9DAA-00D0A1446E5DQ27487496-C920E98C-717C-4C51-8492-C6D1D6BFCAADQ30408331-09BBF6EE-A29E-436B-AA66-10D8EEE0E4ECQ30699740-DD37BBB3-640A-43F7-891A-B7640821FE3CQ36095622-8FBBF878-2590-49EF-8985-84FF78D6157AQ37107624-453AEFD1-C613-4B02-9116-D399D1860370Q37118012-6E0B1CF2-E654-428E-80C4-F6E11F575AB1Q37271884-C3DF2039-1524-44E2-AB4E-C84BB85A5FDCQ37370568-02242F60-E554-4A83-B253-F9C026BD4642Q37628560-B116AC04-30A2-4F91-8652-B3A558809280Q37645094-D340E487-06F2-4ECC-AFE1-2C73E3A1B020Q37823315-A92F77C4-8C6A-42C4-A6FA-A7F929D8C925Q38801807-B68B2649-D6E1-41DF-9ADF-897556A7C1BDQ42198719-4ECBE78C-7345-4E18-934E-57318DDDFEEDQ42921555-780AF173-FBA6-4AD2-B4D6-0B746688375CQ47226785-DF19CF25-CFEA-419E-8D07-83A20E56B3D0Q48349615-12A7FA16-C18F-461A-98F1-E18C65D2329CQ58122091-9F40DC17-AE8E-4C76-B992-A8DA27F1DBC5
P2860
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
@en
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
@nl
type
label
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
@en
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
@nl
prefLabel
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
@en
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
@nl
P2093
P2860
P1433
P1476
Modulation of experimental autoimmune encephalomyelitis by VLA-2 blockade.
@en
P2093
Benjamin J Marble
Catherine Woods
Elias Lazarides
Emily Jane Terry
Robert S Fujinami
P2860
P356
10.1111/J.1750-3639.2006.00042.X
P50
P577
2007-01-01T00:00:00Z